Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
58pct
2d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (4)
2024 · fourth_quarter · Budget/Appropriations
H.R. 766, Dr. Michael C. Burgess Preventive Health Savings Act, all provisions S. 114, Dr. Michael C. Burgess Preventive Health Savings Act, all provisions H.R. 3226, PREEMIE Reauthorization Act of 2023, all provisions S. 1573, PREEMIE Reauthorization Act of 2023, all provisions H.R. 8037, NIH IMPROVE Act, provisions relating to additional funding for research to reduce maternal mortality S. 4147, NIH IMPROVE Act, provisions relating to additional funding for research to reduce maternal mortality H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024, provisions relating to Medicare programs H.R. 4366, Consolidated Appropriations Act, 2024, provisions relating to physician payment cuts H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025, all provisions H.R. 10515, American Relief Act, 2025, provisions relating to Medicare, Continuing Resolution, Telehealth H.R. 9747, Continuing Appropriations and Extensions Act, 2025, provisions relating to CR through December 20 H.R. 3838, Preventing Maternal Deaths Reauthorization Act of 2023, all provisions S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023, all provisions
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $6,590,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
PREEMIE Reauthorization Act (S.1573 /H.R.3226), SHINE for Autumn Act (S.2647/H.R.5012), Preventing Maternal Deaths Act (S.2415/H.R. 3838), Maintaining our Obligation to Moms who Serve Act, (S. 3641/H.R.7087), NIH IMPROVE Act (S. 4147/H.R. 8037)
Client expense: $60,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2024 · fourth_quarter · Health Issues
Abortion access (general); Access to mifepristone (general); Contraception (general); Maternal mortality and morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; Inclusion of pregnant and lactating individuals in research (general); Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of ob-gyn units in rural hospitals on patient access to care and maternal morbidity and mortality; I H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; Telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; S. 712/H.R. 8532, Connected MOM Act; S. 4079/H.R. 8383, Rural Obstetrics Readiness Act; Diversity, Equity, and Inclusion in medicine (general); S. 5236, Keeping Obstetrics Local Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); H.R. 8037/S. 4147, NIH IMPROVE Act; S. 2840, Bipartisan Primary Care and Health Workforce Act; S. 1840/H.R. 3916, SCREENS for Cancer Act; H.R. 10280, Strengthening Pathways to Health Professions Act; S. 5428/S. 10297, Jeanette Acosta Invest in Womens Health Act; S. 3247/H.R. 6298 Stop Shackling and Detaining Pregnant Women Act; H.R. 3503, NIH Clinical Trial Diversity Act; S. 3211/H.R. 6025, Healthcare Workforce Resilience Act; H.R. 3633, PREVENT HPV Cancers Act; S. 1409/H.R. 7891, Kids Online Safety Act; Patient-physician relationship (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); Reproductive health data privacy (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Coverage for infertility (general); Protections for in vitro fertilization (general); HPV vaccination (general); RSV vaccination (general); NIH restructuring (general); NICHD Strategic Plan (general); physician liability (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); NIH/NICHD womens health research (general);; human milk in NICUs; Executive Order 13952; EMTALA implementation (general); Medicare conditions of participation regarding opioids; Paid leave for patients who experience a stillbirth; menthol cigarettes and flavored cigars; nicotine limits in cigarettes; National Strategic Plans for HIV/AIDS, STIs, Vaccines and Viral Hepatitus; environmental health curriculum in medical school; heat-related deaths; hypertension in pregnancy and postpartum; adolescent reproductive health; immediate postpartum LARC; no-cost contraceptive coverage; access to fertility services and treatments; improving postpartum health care visit rates; worksite lactation support programs; newborn nutrition; Levels of Maternal Care; newborn screening; contraceptive and fertility counseling for patients with cancer; access to PrEP; maternal vaccinations; HPV vaccinations; syphilis screening during pregnancy; oral health care during pregnancy; opioid use disorder treatment for pregnant and postpartum individuals.
Client expense: $170,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office
2024 · third_quarter · Health Issues
Abortion access (general); Access to mifepristone (general); Contraception (general); IUD insertion (general); Maternal mortality and morbidity (general); H.R. 1117, Advancing Safe Medications for Moms and Babies Act; Inclusion of pregnant and lactating individuals in research (general); Obstetric and gynecologic care in rural and underserved areas (general); impact of closures of ob-gyn units in rural hospitals on patient access to care and maternal morbidity and mortality; Impact of abortion restrictions on patient outcomes and the ob-gyn workforce (general); H.R. 3305/S. 1606, Black Maternal Health Momnibus Act; H.R. 3310/S. 2239, Kira Johnson Act; H.R. 3312/S. 1602, Moms Matter Act; H.R. 3320/S. 1599, Data to Save Moms Act; H.R. 3523/S. 1710, Perinatal Workforce Act;; H.R. 2389/S. 1302, Resident Physician Shortage Reduction Act; H.R. 2569, Doctors of Community (DOC) Act; Teaching Health Center Graduate Medication Education (general); H.R. 3838/S. 2415, Preventing Maternal Deaths Reauthorization Act of 2023; H.R. 3226/S. 1573, PREEMIE Reauthorization Act of 2023; Telemedicine (general); H.R. 5012/S. 2647, SHINE for Autumn Act; implementation of P.L. 118-69, Maternal and Child Health Stillbirth Prevention Act; Stillbirth prevention (general); S.___, Supporting Healthy Moms and Babies Act; S. 712/H.R. 8532, Connected MOM Act; S. 4079/H.R. 8383, Rural Obstetrics Readiness Act; Diversity, Equity, and Inclusion in medicine (general); S. 5236, Keep Obstetrics Local Act; H.R. 7855, H.R.___, Diane Powis Ovarian Cancer Testing Access Act;; S. 4445, Right to IVF Act; Implementation of P.L. 117-328, Pregnant Workers Fairness Act; National Health Service Corps (general); ; H.R. 8796/S. 4619, Stop Comstock Act; H.R. 8037/S. 4147, NIH Improve Act; H.R. 9886, Broadening Utilization of Proven and Effective Treatment for Recovery Act or the BUPE for Recovery Act; S. 4522, Dads Matter Act; H.R. 6716/S. 3509, Healthy MOM Act; H.R. 8839, Maternal and Infant Syphilis Prevention Act; H.R. 8223/S. 4246 Advancing Menopause Care and Mid-Life Womens Health Act; H.R. 3851/S. 2464, Access to Breast Cancer Diagnosis Act of 2023; S. 964, Mothers and Newborns Success Act; H.R. 4572/S. 2303, Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023; H.R. 4534/S. 2245, Women and Lung Cancer Research and Preventive Services Act of 2023; S. 3447, Pregnant and Postpartum Women Treatment Reauthorization Act; S. 3370, Promoting Maternal and Child Health Through Substance Use Prevention Act; H.R. 3946/S. 1800, FASD Respect Act; H.R. __ /S.__ Strengthening Pathways to Health Professions Act; Health Insurance Portability and Accountability Act (general); Patient-physician relationship (general); Alliance for Innovation on Maternal Health; Residency programs in obstetrics and gynecology (general); Abortion training in obstetrics and gynecology residency programs (general); Obstetrician-gynecologist workforce (general); Reproductive health data privacy (general); Substance use disorder during pregnancy (general); Maternal mental health (general); Coverage for infertility (general); Protections for in vitro fertilization (general); HPV vaccination (general); RSV vaccination (general); Remote patient monitoring (general); Fertility preservation services for sickle cell patients treated with cell and gene therapies; Prenatal supplements (general); Care for pregnant and postpartum incarcerated individuals (general); Gun violence as a public health issue (general);; H.Res.1448, Expressing the sense of the House of Representatives that every person has the basic right to emergency health care, including abortion care; CURES 2.0 Act; NIH restructuring (general); family care plans (general); FDA Advisory Committees (general); FDA Diversity Action Plan (general); NICHD Strategic Plan (general); physician liability (general); pharmacist-prescribed contraceptives (general); Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) recommendations (general); Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) food packages (general); Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability rule (general).
Client expense: $155,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, White House Office
2024 · third_quarter · Health Issues
H.R. 8574, 340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act H.R. 1770, The Equitable Community Access to Pharmacist Services Act H.R. 2389, The Resident Physician Shortage Reduction Act of 2023 H.R. 5378, The Lower Costs, More Transparency Act; Disproportionate Share Hospital (DSH) funding cut repeal; hospital outpatient department payment cuts H.R. 7635, The 340B Pharmaceutical Access to Invest in Essential, Needed Treatments and Support Act of 2024 H.R. 8037/S. 4147, NIH Implementing a Maternal health and Pregnancy Outcomes Vision for Everyone Act, or the NIH IMPROVE Act FY 2025 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act; Congressionally-directed spending/Community project funding issues; Graduate Medical Education (GME) funding; funding for the Antiviral Drug Discovery Centers, pediatric disaster care; medical education; the National Institutes of Health (NIH);the Advanced Research Projects Agency for Health (ARPA-H); and the Children's Hospital Graduate Medical Education Program Hospital Inpatient Prospective Payment System (IPPS); Graduate Medical Education (GME) resident physician slots; hospital allocation issues Issues related to advancing health equity; screening patients for social drivers of health Draft Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act, or the SUSTAIN 340B Act Issues related to learning health systems; reducing the environmental impact of the healthcare sector; incentives for supporting clinical training slots Issues related to the U.S. Department of Educations Basic Needs for Postsecondary Students Program
Client expense: $450,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
2024 · second_quarter · Health Issues
H.R. 8574, 340B Affording Care for Communities and Ensuring a Strong Safety-Net (ACCESS) Act H.R. 1770, The Equitable Community Access to Pharmacist Services Act H.R. 2389, The Resident Physician Shortage Reduction Act of 2023 H.R. 5378, The Lower Costs, More Transparency Act; Disproportionate Share Hospital (DSH) funding cut repeal; hospital outpatient department payment cuts H.R. 7635, The 340B Pharmaceutical Access to Invest in Essential, Needed Treatments and Support Act of 2024 H.R. 8037/S. 4147, NIH Implementing a Maternal health and Pregnancy Outcomes Vision for Everyone Act, or the NIH IMPROVE Act FY 2025 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act; Congressionally-directed spending/Community project funding issues; Graduate Medical Education (GME) funding; funding for the Antiviral Drug Discovery Centers, pediatric disaster care; medical education; the National Institutes of Health (NIH);the Advanced Research Projects Agency for Health (ARPA-H); and the Children's Hospital Graduate Medical Education Program Hospital Inpatient Prospective Payment System (IPPS); Graduate Medical Education (GME) resident physician slots; hospital allocation issues Issues related to advancing health equity; screening patients for social drivers of health Draft Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act, or the SUSTAIN 340B Act Issues related to learning health systems; reducing the environmental impact of the healthcare sector; incentives for supporting clinical training slots Issues related to the U.S. Department of Educations Basic Needs for Postsecondary Students Program
Client expense: $570,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office